Member Exclusive

Japanese Pharmaceutical & Medical Devices Agency

As part of its Japanese partnering strategy, RepliCel seeks advice of Japanese regulators around its fibroblast platform

Go to the profile of Lee Buckler
Mar 23, 2015

Please sign in or register for FREE

Register to RegMedNet

RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.


No comments yet.